• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma--a retrospective review of 182 cases.

作者信息

Yang T S, Ng K T, Wang H M, Wang C H, Liaw C C, Lai G M

机构信息

Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan, R.O.C.

出版信息

Am J Clin Oncol. 1996 Aug;19(4):337-43. doi: 10.1097/00000421-199608000-00003.

DOI:10.1097/00000421-199608000-00003
PMID:8677900
Abstract

Locoregional relapse is the major cause of failure of nasopharyngeal carcinoma (NPC) after radical radiation therapy. The prognosis of such patients is dismal, and the factors related to the outcome are not well identified. Between January 1983 and December 1989, 1,168 new patients with biopsy-proven NPC were seen at this hospital. Eight hundred and eighty-three of these patients were treated uniformly with radical external irradiation and intracavitary treatment with or without chemotherapy. The clinical courses, retreatment outcomes, and prognostic factors for locoregional relapse and subsequent distant metastasis were analyzed. During the follow-up period of 3-10 years or until death, 182 patients (20.6%) developed locoregional relapses without distant metastasis initially. T stage and age were significant prognostic factors for locoregional recurrence. In contrast, histopathologic subtype, N stage, sex, and systemic chemotherapy were not. There were 36 patients (19.8%) who developed subsequent distant metastasis with or without retreatment. The median time from locoregional relapses to distant metastasis was 6 months in this study, and bone was the most frequent and the earliest site of distant metastasis. The N stage at diagnosis, the initial disease-free interval, the presence of neck nodal disease at relapse, and age were the significant factors for predicting the subsequent distant metastasis in locoregionally recurrent NPC patients. We recommend that additional systemic chemotherapy should be considered for retreatment of locoregional relapsed NPC, not only for enhancement of local control but also for eradicating microscopic metastasis as anticipated.

摘要

相似文献

1
Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma--a retrospective review of 182 cases.
Am J Clin Oncol. 1996 Aug;19(4):337-43. doi: 10.1097/00000421-199608000-00003.
2
The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma.淋巴结状态对鼻咽癌初始治疗反应的决定因素及无复发生存模式的影响。
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):867-73. doi: 10.1016/s0360-3016(00)00490-9.
3
Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.鼻咽癌同步局部区域复发的治疗结果
Head Neck. 2003 Jul;25(7):585-94. doi: 10.1002/hed.10242.
4
Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.局部复发性鼻咽癌再治疗的结果及预后因素
Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1099-111. doi: 10.1016/s0360-3016(98)00164-3.
5
Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.鼻咽癌咽旁扩展的预后价值。局部控制和远处转移的一个重要因素。
Cancer. 1996 Jul 15;78(2):202-10. doi: 10.1002/(SICI)1097-0142(19960715)78:2<202::AID-CNCR3>3.0.CO;2-N.
6
Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.辅助化疗增强局部晚期淋巴结阳性鼻咽癌的局部控制
Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):261-71. doi: 10.1016/s0360-3016(98)00383-6.
7
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.T1和T2期鼻咽癌外照射放疗后辅助分次高剂量率腔内近距离放疗
Head Neck. 2004 May;26(5):389-95. doi: 10.1002/hed.10398.
8
A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.调强放疗联合铂类化疗治疗局部区域晚期鼻咽癌的对比研究
Cancer Radiother. 2013 Jul-Aug;17(4):297-303. doi: 10.1016/j.canrad.2013.03.006. Epub 2013 Jul 9.
9
Treatment outcome with brachytherapy for recurrent nasopharyngeal carcinoma.近距离放射治疗复发性鼻咽癌的治疗结果。
Asian Pac J Cancer Prev. 2014 Jan;14(11):6513-8. doi: 10.7314/apjcp.2013.14.11.6513.
10
How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?主要采用外照射的大剂量(≥60 Gy)再程放疗挽救鼻咽癌局部复发的效果如何?
Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):897-913. doi: 10.1016/s0360-3016(97)00854-7.

引用本文的文献

1
Salvage Endoscopic Nasopharyngectomy for Locally Recurrent T1 and T2 Nasopharyngeal Carcinoma.挽救性内镜下鼻咽癌切除术治疗局部复发性T1和T2期鼻咽癌
Indian J Otolaryngol Head Neck Surg. 2023 Sep;75(3):2688-2693. doi: 10.1007/s12070-023-03773-7. Epub 2023 Apr 25.
2
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.基于治疗前鼻咽部 [18F]FDG PET/CT 图像的放射组学分析预测局部复发和远处转移。
Ann Nucl Med. 2021 Apr;35(4):458-468. doi: 10.1007/s12149-021-01585-9. Epub 2021 Feb 4.
3
Correlation of PET-CT, MRI and histopathology findings in the follow-up of patients with nasopharyngeal cancer.
鼻咽癌患者随访中 PET-CT、MRI 与组织病理学检查结果的相关性。
Braz J Otorhinolaryngol. 2021 Nov-Dec;87(6):643-648. doi: 10.1016/j.bjorl.2019.12.004. Epub 2020 Jan 13.
4
Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.磁共振扩散加权成像对鼻咽癌放疗后局部及颅底复发的诊断价值
Medicine (Baltimore). 2018 Aug;97(34):e11929. doi: 10.1097/MD.0000000000011929.
5
PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis.过氧化物酶体增殖物激活受体β/δ激动剂GW501516通过促进凋亡抑制C666-1细胞中未分化鼻咽癌的致瘤性。
Front Pharmacol. 2018 Jun 28;9:648. doi: 10.3389/fphar.2018.00648. eCollection 2018.
6
Value of F-FDG heterogeneity for discerning metastatic from benign lymph nodes in nasopharyngeal carcinoma patients with suspected recurrence.¹⁸F-FDG异质性在鼻咽癌疑似复发患者鉴别转移性与良性淋巴结中的价值
Br J Radiol. 2016 Nov;89(1067):20160109. doi: 10.1259/bjr.20160109. Epub 2016 Sep 21.
7
Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma.鉴定用于鼻咽癌免疫治疗的四关节盒1(FJX1)特异性肽段。
PLoS One. 2015 Nov 4;10(11):e0130464. doi: 10.1371/journal.pone.0130464. eCollection 2015.
8
MEK inhibitor diminishes nasopharyngeal carcinoma (NPC) cell growth and NPC-induced osteoclastogenesis via modulating CCL2 and CXCL16 expressions.MEK抑制剂通过调节CCL2和CXCL16的表达来减少鼻咽癌(NPC)细胞的生长以及NPC诱导的破骨细胞生成。
Tumour Biol. 2015 Nov;36(11):8811-8. doi: 10.1007/s13277-015-3595-8. Epub 2015 Jun 10.
9
Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma.评估鼻咽癌短期疾病局部复发的分子标志物。
Oncol Rep. 2015 Mar;33(3):1418-26. doi: 10.3892/or.2015.3739. Epub 2015 Jan 20.
10
The role of microRNAs in nasopharyngeal carcinoma.微小RNA在鼻咽癌中的作用。
Tumour Biol. 2015 Jan;36(1):69-79. doi: 10.1007/s13277-014-2847-3. Epub 2014 Nov 27.